Login
Toggle navigation
Videos
Categories
Trending
Thoughts on gaming in crypto, NFTs, work-life balance and more|Ramnik Arora,Head of Product,FTX
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Founder of Toy Ventures. Attended Stanford University.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Focused on early stage growth capital late stage and startup financing|Albert Wenger,Managing Partner,Union Square Ventures
00:10:00
Theta Gold Mines: Progressing Towards Production at the One-to-One Mining Investment Conference
00:10:00
Leadership Perspectives on Investor Protection and Risk Management | Tim Buckley, CEO , Vanguard .
00:10:00
Keystone Global Network Helped Me Overcome My Visa Challenges and Secure a Scholarship
00:10:00
PE firms are more often reaching the investment term limits of their mandates|Shad F. Azimi, Managing Partner,Vanterra Capital Ltd.
00:10:00
Renewable Energy Innovator Explores Carbon Abatement Solutions and Profitability | Dr Jessica North, CEO, Lgi Ltd.
00:10:00
Enhancing Advisor Efficiency: Insights from The Rudin Group, Celent, and NexJ Systems - April Rudin | Founder and President, The Rudin Group
00:10:00
Highlights from BLTG Capital Markets Day on June 3, 2020 | Matt Jones, CEO, Blancco Technology Group PLCBLTG:LSE
00:10:00
Capital Product Partners, a company affiliated with Vangelis Marinakis, recorded a significant increase in profits in the third quarter of 2021.|Jerry Kalogiratos, CEO of Capital Product Partners L.P.
00:10:00
Get River Diamonds Limited: Developing the Blina Alluvial Diamond Project in Western Australia
00:10:00
CEO Discusses Strategic Vision for Environmental, Social, and Governance Initiatives|Gianfranco Nazzi, CEO, Almirall SA.
00:10:00
Legacy in the Making: Rajiv Jain's Evolution as a Financial Steward | Rajiv Jain, Chairman , GQG Partners.